Skip to main content
An official website of the United States government
Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

News

2025 NCORP Awardees: Kathleen Yost Butler, M.D., Kamara Mertz-Rivera, Kathleen Yost Butler, M.D., and Kamara Mertz-Rivera

NCORP recognizes Kathleen Yost Butler, Kamara Mertz-Rivera, Jordan Vogelsberg with 2025 awards

POSTED: September 12, 2025
SOURCE: DCP News

The NCI Community Oncology Research Program (NCORP) selected Kathleen Yost Butler, M.D., and Kamara Mertz-Rivera, M.A., CCRC, as recipients of this year’s outstanding principal investigator (PI) and administrator,…
Cover image of Cancer Care for The Whole Patient report.
Researchers Seek to Care for the Whole Patient
In 2012, Patricia Ganz, M.D., saw a 39-year-old cancer survivor for a consultation who had a long-term history of anxiety during medical visits. The woman had been diagnosed with Hodgkin lymphoma when she was 23 years old.… Learn more
POSTED: 8/10/2022
SOURCE: Cancer Prevention Science Blog
AUTHOR: Jack J. Lee, Ph.D.
An example of a nonendometrioid cancer.
Rising Endometrial Cancer Rates Spur New Approaches to Prevention
Unlike many other cancers, the incidence and death rates for uterine cancer are rising. Rates of new uterine cancer cases have risen 0.6% per year from 2010-2019, and death rates have risen an average of 1.7% per year for… Learn more
POSTED: 6/28/2022
SOURCE: Cancer Prevention Science Blog
AUTHOR: Jack J. Lee, Ph.D.
Established Risk Factors for Developing Female Breast Cancer
Large Studies Evaluating How to Personalize Breast Cancer Screening for All Women
In the era of personalized medicine, prevention and screening for breast cancer are evolving toward new approaches that assess each woman’s risk and lifestyle factors. All women do not carry the same risk for the same type… Learn more
POSTED: 5/6/2022
SOURCE: Cancer Prevention Science Blog
Precision cancer screening and prevention strategies: population risk, biological risk, modality, delivery
How Precision Cancer Prevention Can Promote Health Equity
Overall, cancer death rates in the United States have been declining about 2% per year, current SEER data from 2014 through 2018 show. However, these improvements have not been experienced equally by everyone, which is one… Learn more
POSTED: 4/18/2022
SOURCE: Cancer Prevention Science Blog
AUTHOR: Jack J. Lee, Ph.D.
An illustration displaying signal amplification.
Engineering Synthetic Biomarkers for Early Detection of Cancers
Tumor cells release telltale molecules into blood, urine, and other bodily fluids. But it can be difficult to detect tumor-derived DNA, RNA, and proteins in the earliest stages of disease, when cancers can be easier to treat… Learn more
POSTED: 2/9/2022
SOURCE: Cancer Prevention Science Blog
AUTHOR: Jack J. Lee, Ph.D.
An illustration of a displaying a bronchoscopy, entering via nasal swabs to detect a suspicious nodule.
Identifying New Biomarkers to Detect Lung Cancer Earlier
Lung cancer, the leading cause of cancer deaths worldwide killing 1.8 million people each year, is often diagnosed at an advanced stage when the chances for a cure are limited. In the United States, almost 60% of people… Learn more
POSTED: 1/14/2022
SOURCE: Cancer Prevention Science Blog
AUTHOR: Jack J. Lee, Ph.D.
Thank You--50th Anniversary of the National Cancer Act
Ending Cancer as We Know It Is the Work of Many Capable Hands: A Moment to Say "Thank You"
Fifty years ago this week, the National Cancer Act was signed into law, kick-starting research that has changed how cancer is prevented, detected, diagnosed, treated, and survived, and moving us closer to a time when no one… Learn more
POSTED: 12/20/2021
SOURCE: Cancer Prevention Science Blog
AUTHOR: Philip E. Castle, Ph.D., M.P.H.
An illustration displaying possible inherited risk carriers within a family.
Studies Focus on Testing Family Members of Cancer Gene Carriers
If your family member had cancer, would you want to know if you carried a gene mutation that increased your risk of the same cancer? This question is at the heart of three novel research projects underway to determine how… Learn more
POSTED: 11/29/2021
SOURCE: Cancer Prevention Science Blog
Equity and Access to Trials Highlight the 2021 NCORP Grantee Meeting
The NCI Community Oncology Research Program (NCORP) annual meeting for grantees in August 2021 virtually brought together representatives from every NCORP Research Base and Community and Minority Underserved Site to discuss… Learn more
POSTED: 11/10/2021
SOURCE: Cancer Prevention Science Blog